# Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

> **NCT03549819** · PHASE3 · UNKNOWN · sponsor: **McMaster University** · enrollment: 50 (estimated)

## Conditions studied

- Generalized Anxiety Disorder
- Social Anxiety Disorder
- Panic Disorder
- Agoraphobia

## Interventions

- **DRUG:** Cannabidiol (CBD) Oil Capsules
- **DRUG:** Sunflower Lecithin Oil in Capsule

## Key facts

- **NCT ID:** NCT03549819
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-15
- **Primary completion:** 2023-12-15
- **Final completion:** 2024-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03549819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03549819, "Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03549819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*